Skip to main content
. 2019 Jun 27;8(1):1627164. doi: 10.1080/20013078.2019.1627164

Figure 2.

Figure 2.

The effect of brain tumour-derived EVs on immune cells. EVs derived from primary brain tumour cells can induce an M2 phenotype in microglia and decrease the cytotoxicity of the CD8 + T cells. Metastatic brain tumour EVs can activate microglia through the TLR receptor.